Page 1,924«..1020..1,9231,9241,9251,926..1,9301,940..»

Category Archives: Transhuman News

Fish study shows important genome interactions in animal cells – Phys.Org

Posted: April 5, 2017 at 4:23 pm

April 4, 2017 A salt water marsh, where F. heteroclitus naturally occur. Individuals used in the study were collected in marshes in Mantoloking, NJ. Inset: a male F. heteroclitus. Credit: Douglas Crawford

In a new study, researchers at the University of Miami (UM) Rosenstiel School of Marine and Atmospheric Science examined how the interaction of two genomes in animal cellsthe mitochondrial and nuclear genomesinteract to affect adaptation of the Atlantic killifish to different temperatures. They showed that although these genomes are separate physical entities, the mitochondrial genome affects the evolution of the nuclear genome, the genetic material responsible for variations in most traits such as hair color and height.

Interactions between these two genomes, which affect everything from health and physiology to fitness, have important consequences for human health and medical interventions such as mitochondrial replacement therapy in embryos.

All animal cells are made up of two genomes, the nuclear genome with 10,000s of protein coding genes and the mitochondrial genome with 13 protein-encoding genes. All 13 genes from the mitochondrial genome interact with approximately 76 nuclear genes in a single metabolic pathwaycalled the oxidative phosphorylation pathwaythat produces nearly all the metabolic energy needed for animal cells. This study found that the interaction between these genomes and the implications on energy production is strong enough that the mitochondrial genome can alter which version of a gene is present in the nuclear genome.

Using Atlantic killifish (Fundulus heteroclitus), the researchers examined whether mitochondrial-nuclear interactions alter the frequency of alternative forms of a gene that arise by mutation, called alleles, for over 11,000 nuclear DNA sequence variations within a population of the fish with mixed ancestry. Among individuals with two divergent mitochondrial haplotypes (mt-haplotypes), the genome-wide analyses revealed significant differences in nuclear allele frequencies.

"Our results suggest that metabolic fitness is not simply a function of the mitochondria but instead is reliant on mitochondrial-nuclear interactions and therefore important for our understanding of physiology, human health and evolution," said Doug Crawford, professor of marine biology and ecology at the UM Rosenstiel School.

The study, titled "Evolved genetic and phenotypic differences due to mitochondrial-nuclear interactions," was published in the March 31, 2017 issue of the journal PLoS Genetics.

Explore further: New species concept based on mitochondrial & nuclear DNA coadaptation

More information: Tara Z. Baris et al, Evolved genetic and phenotypic differences due to mitochondrial-nuclear interactions, PLOS Genetics (2017). DOI: 10.1371/journal.pgen.1006517

Journal reference: PLoS Genetics

Provided by: University of Miami

What is a species? Biologistsand ornithologists in particularhave been debating the best definition for a very long time. A new commentary published in The Auk: Ornithological Advances proposes a novel concept: that ...

Mitochondrial replacement therapy (MRT) has now been used in humans to conceive a "three-parent baby" to prevent inherited mitochondrial disorders, but there remain questions about the effectiveness of the process.

The way we age might be determined long before the aging process starts and the first signs appear. Scientists at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), in partnership with groups at the ...

(Medical Xpress) -- Researchers have discovered the first real evidence of the 'mother's curse' and its connection to male infertility due to genetic mutations in mitochondria. Led by Dr. Damian Dowling from Monash University ...

(Phys.org)Plantandanimal cells contain two genomes: one in the nucleus and one in the mitochondria. When mutations occur in each, they can become incompatible, leading to disease. To increase understanding of such ...

Diseases caused by genetic mutations in the mitochondria the powerhouses of the cell can be disabling, or even deadly. That is why mitochondrial replacement therapy (MRT), otherwise also known as three-person IVF ...

What's brightly colored, lives on shipwrecks, filter-feeds like a whale, and shoots webs like Spiderman? If you can't readily come up with an answer, that's okay: until now, such animals weren't known to science. But as of ...

When whiteflies take off, they don't just spread their wings and fly. Just .03 of an inch long, these tiny insects possess a variety of sophisticated techniques that provide them with exceptional stability in the air. Tel ...

Great apes help a person access an object when that person thinks they knowswhere it is but is mistaken, according to a study published April 5, 2017 in theopen-access journal PLOS ONE by David Buttelmann from Max Planck ...

(Phys.org)A team of researchers from several institutions in Germany has found that middle-age killifish fed the gut contents of younger killifish lived longer than normal. In their paper uploaded to the bioRxiv preprint ...

An American who fell in love with both the Great Barrier Reef and his wife via The University of Queensland has led a breakthrough discovery that could protect one of the Seven Natural Wonders. Husband-and-wife Professor ...

A detailed analysis of 39 U.S. fisheries by Duke University economists offers strong new evidence that catch shares curb the "race to fish" that compresses fishing seasons.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Read more here:
Fish study shows important genome interactions in animal cells - Phys.Org

Posted in Genome | Comments Off on Fish study shows important genome interactions in animal cells – Phys.Org

Morphing Genomes Can Harm and Help – UConn Today

Posted: at 4:23 pm

Imagine reading a blueprint thats 3.2 billion pages long.

Thats how many strands of DNA make up the human genome, the set of instructions that makes each of us who we are. Geneticists like UConn professor Rachel ONeill of the Department of Molecular & Cell Biology are deciphering that expansive blueprint to help us better understand the building blocks of life.

We now know the order and structure of between 80 to 90 percent of the human genome, ONeill said. Today, the field of genomics and the accompanying technology thats been developed has expanded to examining how DNA interacts within a single cell and how different genes are active in different tissues and even single cells across complex tissues, such as the brain.

ONeill noted that genomes can morphwhich presents the next challenges in genomic research. She focuses her research on understanding this instability: why in some cases its detrimental, such as with cancer, or how, in other cases, it provides opportunities for new species to evolve or adapt to their environment.

The focus of this effort is on the DNA in our genome that is considered selfish and recently evolved. Retroviruses are an example of that kind of DNA that our genomes all have, ONeill said. More specifically, I work on trying to understand why our genomes remain stable most of the time, while every so often a genome can fall into relative chaos or instability.

While most of us dont think about our genome every day, this type of research can have a significant impact on our lives.

It is tightly tied to our perception of ourselves in so many respects, ONeill said. For example, when we go into a doctors office and fill in the family history form, we are providing some genetic information that will guide the diagnosis and treatment of patients. Another relevance is that genomic information is a future diary in some respects as to what may happen to us as we age. Because of this, genetic information has to be handled very differently than other medical tests. For example, a cholesterol screening says something about your metabolism; but it can be altered with diet and exercise, so its not a permanent record.

ONeill oversees UConns Center for Genome Innovation, which supports faculty and student research with state-of-the-art technology, technical support, and grant project assistance. Additionally, the Center supports more than 100 labs across UConn Health and the Storrs and Avery Point campuses, so ONeill stays busy researching and mentoring students.

One of my recent memorable moments is when a student came running into my office having experienced the same discovery excitement I had as a grad student, this time on her own research, she said. She found that the retrovirus we were working on was a primary component of the chromosome we were studying. That was a gold moment!

As she continues her work on the human genome, one of her priorities as a scientist is to relate her research back to the public.

One of my goals is to promote the idea that the study of genetics is important, ONeill said. Understanding genomes can tell us so much about ourselves and our world. The study of genomics is increasingly intersecting with individuals at the most personal level, with a potential to shape the future of healthcare.

Take a tour of the Center for Genome Innovation: cgi.uconn.edu.

This article was first posted in the UConn Foundations online newsletter, Inside UConn Nation.

Continued here:
Morphing Genomes Can Harm and Help - UConn Today

Posted in Genome | Comments Off on Morphing Genomes Can Harm and Help – UConn Today

Bionano Genomics Announces Immediate Availability of New Suite of Genomic Analysis Tools – Technology Networks

Posted: at 4:23 pm

Bionano Genomics has announced the immediate availability of its entirely new suite of tools for genome assembly, structural variation (SV) detection, and visualization of the genomes true structure. The Bionano Access 1.0 and Bionano Solve 3.0 software tools are released as a free download, and will be introduced during two live webinars on Wednesday, April 5.

Mark Borodkin, Bionanos Vice President, Systems Development, commented, With Bionano Access and our updated Bionano Solve analysis pipeline, we are making it easier than ever for scientists to get more value from Bionano genome maps related to their genome research. Following feedback from our customers, we have designed Bionano Access to be feature-rich, fast and intuitive. Bionano Access is also a browser-based application, allowing it to be run on an enterprise server or a lightweight laptop; Linux, Windows, macOS supported. Coupled with Bionano Solve, Bionano Access provides a powerful set of new tools for identifying structural variants or performing hybrid scaffolding, and this will benefit any scientist studying the true structure of the genome.

Bionano Access centralizes all software tools required to generate, edit, analyze and visualize Bionano maps. For Irys users, it replaces the IrysView software. It enables visualization of Bionano results in a web browser, providing instantaneous interaction with Bionano maps used for the scaffolding and SV applications.

Bionano Access also comes with a powerful variant annotation pipeline that can filter out common variants based on a database of controls, analyze trios or two samples to identify inherited and de novo SVs, and visualize and export in a dbVar-compliant VCF file for downstream analysis.

Hybrid scaffolding is enhanced with map editing, improved two-enzyme scaffolding and NCBI-compliant data exporting.

When connected with the Saphyr System it allows users to set-up experiments, start runs, monitor data quality metrics in real-time and automatically start de novo assemblies and SV discovery analysis when enough data is collected.

The Bionano Solve 3.0 assembly pipeline within Bionano Access allows users to run SV analysis or hybrid scaffolding. Bionano Solve 3.0 automatically calls SVs with unprecedented sensitivity. Insertions and deletions larger than 1 kilobasepair (kbp) are detected with more than 90% sensitivity and translocations with 98% sensitivity. Significant improvements to translocation calling and masking of common variants significantly reduces the false positive translocation calls.

The pipeline also significantly improves the hybrid scaffolding application by integrating two genome maps created separately with different nicking enzymes. Compared to the prior version, the new two-enzyme hybrid scaffolding incorporates up to 50% more NGS contigs in the assembly, improves contiguity significantly and allows for improved resolving of conflicts and correction of chimeric sequence contigs. This application continues to support any NGS data of suitable quality.

Bionano has validated these tools across a variety of patient samples, including those with undiagnosed disorders and leukemia.

We have applied Bionano genome mapping technology to a variety of cancer cell lines and primary patient leukemia samples and compared our results to those obtained by other genome mapping techniques, such as cytological karyotyping and whole genome sequencing, said James Broach, chair of Biochemistry and Molecular Biology, Pennsylvania State College of Medicine. In all cases, using the Bionano technology, we were able to detect all the translocations identified by these other techniques but were also able to detect many more translocations that had not been identified by those techniques. Moreover, we also detected hundreds of deletions and insertions that could not be seen by these other methodologies and therefore whose role in cancer onset and progression have not been evaluated. Given increased speed, lower cost, higher sensitivity and greater reliability of the Bionano technology, we surmise that it may supplant classical cytology as the primary method for clinical detection of genomic structural variation.

Bionano is introducing key new features in Bionano Access and Bionano Solve during two webinars on Wednesday April 5th, at 9 am and at 6 pm PDT / 12 pm and 9 pm EDT. They can be found online here Webinar 1: April 5th, 9am PDT and Webinar 2: April 5th, 6pm PDT and will be available shortly thereafter for replay on the Bionano website on new support pages dedicated to Bionano Access and Bionano Solve.

View original post here:
Bionano Genomics Announces Immediate Availability of New Suite of Genomic Analysis Tools - Technology Networks

Posted in Genome | Comments Off on Bionano Genomics Announces Immediate Availability of New Suite of Genomic Analysis Tools – Technology Networks

Unique genome architectures after fertilization in single-cell embryos – Science Daily

Posted: at 4:23 pm

Unique genome architectures after fertilization in single-cell embryos
Science Daily
After fertilization, maternal and paternal genomes erase some of the epigenetic memory of the previously differentiated states in order to facilitate the beginning of new life as the zygote. In the first cell cycle after fertilization the maternal ...

Visit link:
Unique genome architectures after fertilization in single-cell embryos - Science Daily

Posted in Genome | Comments Off on Unique genome architectures after fertilization in single-cell embryos – Science Daily

Eczema: Diagnosis and Treatment – WebMD

Posted: at 4:22 pm

It can be hard to tell for sure if you have eczema. Youll want to see a dermatologist or other doctor to find out.

At your appointment, your doctor will check your skin and talk with you about your symptoms, your health history in general, and any rashes or allergies that run in your family.

Based on that information, she'll decide if its eczema or something else.

Goodskincare is key. If your eczema is mild, that might be all you need, along with some changes in your daily habits.

If you have severe eczema, you may need to takemedicine for it, too.

The basics:

Soap and moisturizer. Use a mild soap or soap substitute that won't dry your skin. Youll also want a good moisturizer in cream, lotion, or ointment form. Smooth it on right after a shower or bath, as well as one other time each day.

If your eczema is severe, you may find that it helps to take baths with a small amount of bleach added to the water. That kills bacteria that live on the skin of people with eczema.

Short, warm showers. Dont take very hot or very long showers or baths. They can dry out your skin.

Stress management. Get regularexercise,and set aside time to relax. Need a few ideas? You could get together with friends, laugh, listen to music, meditate or pray, or enjoy a hobby.

Get a humidifier. Dry air can be stressful for your skin.

If your doctor decides you need meds to treat your eczema, those may include:

Hydrocortisone. Over-the-counter cream or ointment versions of it may help mild eczema. If yours is severe, you may need a prescription dose.

Antihistamines. Ones you take by mouth are available over-the-counter and may help relieve symptoms. Some of these make you drowsy, but others dont.

Corticosteroids. Your doctor may prescribe these if other treatments dont work. Always follow your doctor's directions when taking steroids by mouth.

Ultraviolet light therapy.This may help if your skin condition is severe.

Drugs that work on your immune system.Your doctor may consider these medicines -- such asazathioprine, cyclosporine, ormethotrexate -- if other treatments dont help. There are also prescription creams that treat eczema by controlling inflammation and reducing the immune system reactions. Examples include pimecrolimus (Elidel)andtacrolimus (Protopic), which you should only use for a short time if other treatments don't work -- and you should never use them on kids younger than 2, according to the FDA.

Prescription-strength moisturizers.These support the skins barrier.

SOURCE: American Academy of Dermatology.

See the original post:
Eczema: Diagnosis and Treatment - WebMD

Posted in Eczema | Comments Off on Eczema: Diagnosis and Treatment – WebMD

FDA approves 1st drug for severe eczema cases | Northwest Herald – Northwest Herald

Posted: at 4:22 pm

TRENTON, N.J. U.S. regulators have approved the first powerful, injected medicine to treat serious cases of the skin condition eczema.

The Food and Drug Administration on Tuesday approved Dupixent for moderate or severe eczema, which causes red, fiercely itchy rashes on the face, arms and legs.

In three studies of the drug including a total of 2,119 participants, one-third to two-thirds achieved clear or nearly clear skin. About 4 in 10 had itching decrease sharply, bringing better sleep and reducing anxiety and depression.

Dupixent will have an initial list price of $37,000 a year, according to Paris, France-based Sanofi SA and Regeneron Pharmaceuticals of Tarrytown, New York, which developed the drug.

Eczema treatments generally have been limited to topical medications, steroid creams, moisturizers and ultraviolet light, plus antihistamines to relieve itching. Those work fairly well for mild eczema, but not the severe form, also called atopic dermatitis. Its also the most common form.

Wire reports

Eczema often begins in young children, and most grow out of it, said Dr. Lisa Beck, a dermatology professor at the University of Rochester Medical Center in Rochester, New York.

But for other patients, the condition persists throughout adulthood, tormenting patients with relentless itching that triggers scratching, and with that, skin swelling, cracking, weeping of clear fluid and, eventually, thickening of the skin, according to the FDA.

Many of these patients gave up on health care because we offered them nothing new for years and years, said Beck, a member of the National Eczema Associations scientific advisory board who participated in patient tests of Dupixent, also called dupilumab.

The drug is an antibody thats injected just under the skin. It works by binding to a specific protein to inhibit the immune systems inflammatory response.

___

Follow Linda A. Johnson at https://twitter.com/LindaJ_onPharma

See the rest here:
FDA approves 1st drug for severe eczema cases | Northwest Herald - Northwest Herald

Posted in Eczema | Comments Off on FDA approves 1st drug for severe eczema cases | Northwest Herald – Northwest Herald

FDA approves Dupixent to treat moderate-to-severe eczema – Clinical Advisor

Posted: at 4:22 pm


Clinical Advisor
FDA approves Dupixent to treat moderate-to-severe eczema
Clinical Advisor
(HealthDay News) Dupixent (dupilumab) has been approved by the US Food and Drug Administration to treat moderate-to-severe eczema that isn't well controlled by topical medication. The active ingredient in Dupixent is an antibody (dupilumab) that ...
Dupixent: Eczema's Most Powerful Cure, Approved By FDA ...Science Times
FDA approves Sanofi and Regeneron's new eczema drugEuropean Pharmaceutical Review
FDA Approves $37,000/Yr Eczema Drug | Healthcare PackagingHealthcare Packaging

all 6 news articles »

Read more here:
FDA approves Dupixent to treat moderate-to-severe eczema - Clinical Advisor

Posted in Eczema | Comments Off on FDA approves Dupixent to treat moderate-to-severe eczema – Clinical Advisor

In psoriasis, report shows Taltz closing in on Cosentyx – The Pharma Letter (registration)

Posted: at 4:21 pm

Two independent surveys of 200 rheumatologists and dermatologists have unveiled recent developments

To continue reading this article and to access exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space you need to be logged into the site and have an active subscription or trial subscription. Please loginorsubscribe in order to continue reading. Claim a week's trial subscriptionby signing up for free today and receive our daily pharma and biotech news bulletin free of charge, forever.

CosentyxDermatologicalsEli LillyNovartisPharmaceuticalResearchTaltzUSA

Access The Pharma Letter's latest news free for 7 days

PLUS... you can receive the Pharma Letter headlines and news roundup email free forever

Click here to take a free trial

Unlimited access to The Pharma Letter site for a whole year Only 77 per month or 820 per year

Click here to subscribe

See original here:
In psoriasis, report shows Taltz closing in on Cosentyx - The Pharma Letter (registration)

Posted in Psoriasis | Comments Off on In psoriasis, report shows Taltz closing in on Cosentyx – The Pharma Letter (registration)

PASI Scores Differ Between Sexes in Psoriasis – Monthly Prescribing Reference (registration)

Posted: at 4:21 pm

April 03, 2017

No differences in medication use before enrollment could explain these gender differences

HealthDay News Women have lower median Psoriasis Area and Severity Index (PASI) scores than men, according to a study published online March 24 in the American Journal of Clinical Dermatology.

David Hgg, from Ume University in Sweden, and colleagues examined the sex differences in the severity of psoriasis using the PASI and the distinct elements of the PASI score in a cross-sectional study involving 5,438 patients experiencing moderate-to-severe psoriasis.

The researchers found that across all ages, women had statistically significantly lower median PASI scores than men (5.4 versus 7.3; P<0.001). Women had significantly lower scores in all areas of the body than men, except for the head, in itemized PASI analyses. There were no differences in medication use prior to enrollment that could have caused these differences.

"These findings motivate a gender perspective in the management of psoriasis and in the prevention and management of its comorbidities," the authors write.

Abstract/Full Text

See the article here:
PASI Scores Differ Between Sexes in Psoriasis - Monthly Prescribing Reference (registration)

Posted in Psoriasis | Comments Off on PASI Scores Differ Between Sexes in Psoriasis – Monthly Prescribing Reference (registration)

Study reverses thinking on genetic links to stress, depression – Washington University School of Medicine in St. Louis

Posted: at 4:20 pm

Visit the News Hub

Scientists re-examine data exploring connection between serotonin gene, depression, stress

For years, scientists have been trying to determine what effect a gene linked to the brain chemical serotonin may have on depression in people exposed to stress. But now, analyzing information from more than 40,000 people who have been studied over more than a decade, researchers led by a team at Washington University School of Medicine in St. Louis have found no evidence that the gene alters the impact stress has on depression.

New research findings often garner great attention. But when other scientists follow up and fail to replicate the findings? Not so much.

In fact, a recent study published in PLOS One indicates that only about half of scientific discoveries will be replicated and stand the test of time. So perhaps it shouldnt come as a surprise that new research led by Washington University School of Medicine in St. Louis shows that an influential 2003 study about the interaction of genes, environment and depression may have missed the mark.

Since its publication in Science, that original paper has been cited by other researchers more than 4,000 times, and some 100 other studies have been published about links between a serotonin-related gene, stressful life events and depression risk. It indicated that people with a particular variant of the serotonin transporter gene were not as well-equipped to deal with stressful life events and, when encountering significant stress, were more likely to develop depression.

Such conclusions were widely accepted, mainly because antidepressant drugs called selective serotonin reuptake inhibitors (SSRIs) help relieve depression for a significant percentage of clinically depressed individuals, so many researchers thought it logical that differences in a gene affecting serotonin might be linked to depression risk.

But in this new study, the Washington University researchers looked again at data from the many studies that delved into the issue since the original publication in 2003, analyzing information from more than 40,000 people, and found that the previously reported connection between the serotonin gene, depression and stress wasnt evident. The new results are published April 4 in the journal Molecular Psychiatry.

Our goal was to get everyone who had gathered data about this relationship to come together and take another look, with each research team using the same tools to analyze data the same way, said the studys first author, Robert C. Culverhouse, PhD, an assistant professor of medicine and of biostatistics. We all ran exactly the same statistical analyses, and after combining all the results, we found no evidence that this gene alters the impact stress has on depression.

Over the years, dozens of research groups had studied DNA and life experiences involving stress and depression in the more than 40,000 people revisited in this study. Some previous research indicated that those with the gene variant were more likely to develop depression when stressed, while others didnt see a connection. So for almost two decades, scientists have debated the issue, and thousands of hours of research have been conducted. By getting all these groups to work together to reanalyze the data, this study should put the questions to rest, according to the researchers.

The idea that differences in the serotonin gene could make people more prone to depression when stressed was a very reasonable hypothesis, said senior investigator Laura Jean Bierut, MD, the Alumni Endowed Professor of Psychiatry at Washington University. But when all of the groups came together and looked at the data the same way, we came to a consensus. We still know that stress is related to depression, and we know that genetics is related to depression, but we now know that this particular gene is not.

Culverhouse noted that finally, when it comes to this gene and its connection to stress and depression, the scientific method has done its job.

Experts have been arguing about this for years, he said. But ultimately the question has to be not what the experts think but what the evidence tells us. Were convinced the evidence finally has given us an answer: This serotonin gene does not have a substantial impact on depression, either directly or by modifying the relationship between stress and depression.

With this serotonin gene variant removed from the field of potential risk factors for depression, Culverhouse and Bierut said researchers now can focus on other gene-environment interactions that could influence the onset of depression.

Culverhouse, RC, et al. Collaborative meta-analysis finds no evidence of a strong interaction between stress and 5-HTTLPR genotype contributing to the development of depression. Molecular Psychiatry. April 4, 2017.

This work was supported by the National Institute on Drug Abuse and the National Institute of Mental Health of the National Institutes of Health (NIH), grant numbers R21 DA033827, MH089995 and R01 DA026911. Other funding provided by the Wellcome Trust and other funding agencies from countries around the world. For a complete list of funding agencies and grants, please refer to the paper.

Potential conflicts of interest involving researchers who are authors of the study also are listed at the end of the paper. Some have received consultancy/speaking fees from various pharmaceutical companies and other business interests. LJ Bierut is one of the listed inventors on US Patent 8 080 371, Markers for Addiction, covering the use of certain DNA SNPs in determining the diagnosis, prognosis and treatment of addiction.

Washington University School of Medicines 2,100 employed and volunteer faculty physicians also are the medical staff of Barnes-Jewish and St. Louis Childrens hospitals. The School of Medicine is one of the leading medical research, teaching and patient-care institutions in the nation, currently ranked seventh in the nation by U.S. News & World Report. Through its affiliations with Barnes-Jewish and St. Louis Childrens hospitals, the School of Medicine is linked to BJC HealthCare.

Read more here:
Study reverses thinking on genetic links to stress, depression - Washington University School of Medicine in St. Louis

Posted in Gene Medicine | Comments Off on Study reverses thinking on genetic links to stress, depression – Washington University School of Medicine in St. Louis

Page 1,924«..1020..1,9231,9241,9251,926..1,9301,940..»